U.K. Regulator To “Streamline” Switch Approach With Guidance

This article was originally published in The Tan Sheet

17 Dec 2012
News

Malcolm Spicer @TheTanSheet malcolm.spicer@informa.com

Executive Summary

U.K.’s health authority issued guidance that industry representatives say will help cut months off the time to reclassify a prescription drug to nonprescription, Pharmacy sale. OTC trade group emphasizes the guideline calls for more engagement before firms submit applications.

Already Registered? Sign in to continue reading.

New to Pink Sheet? Start a free trial today!

Table
View full table

Topics

United Kingdom

ASK THE ANALYST
Email

Print
Bookmark
Share

Tags:

BioPharmaceutical Consumer United Kingdom

You must sign in to use this functionality

Authentication.SignIn.HeadSignInHeader

PS106144

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

PS106144

All set! This article has been sent to my@email.address.

All fields are required. For multiple recipients, separate email addresses with a semicolon.

Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.

U.K. Regulator To “Streamline” Switch Approach With Guidance

News

Executive Summary

Related Content

European OTC Switch Still Muted By Regulatory Resistance

Topics

You must sign in to use this functionality

Authentication.SignIn.HeadSignInHeader

Register

Ask The Analyst

Email Article

Sign In To Set a Search Alert